CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Measuring Disease Progression in Early Parkinson Disease

(2014) Sotirios A. Parashos et al.   JAMA Neurology

APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease

(2014) Ignacio F. Mata et al.   JAMA Neurology

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

(2013) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

(2013) Jing L. Guo et al.   CELL

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

(2013) David J. Irwin et al.   NATURE REVIEWS NEUROSCIENCE

Neuropathologic substrates of Parkinson disease dementia

(2012) David J. Irwin et al.   ANNALS OF NEUROLOGY

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

(2012) S. N. Gomperts et al.   NEUROLOGY

APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies

(2012) Debby Tsuang et al.   JAMA Neurology

Neuropathology underlying clinical variability in patients with synucleinopathies

(2011) Glenda M. Halliday et al.   ACTA NEUROPATHOLOGICA

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

(2011) Lucilla Parnetti et al.   MOVEMENT DISORDERS

Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease

(2011) Wilma D.J. van de Berg et al.   PARKINSONISM & RELATED DISORDERS

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

(2010) Jonathan Wills et al.   EXPERIMENTAL NEUROLOGY

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease

(2009) Sotirios A. Parashos   ARCHIVES OF NEUROLOGY

A clinico-pathological study of subtypes in Parkinson's disease

(2009) M. Selikhova et al.   BRAIN

α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson’s disease models

(2009) Tetyana Duka et al.   FASEB JOURNAL

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease

(2009) C. H. Williams-Gray et al.   JOURNAL OF NEUROLOGY

The epidemiology of dementia associated with Parkinson disease

(2009) Dag Aarsland et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Course in Parkinson disease subtypes: A 39-year clinicopathologic study

(2009) A. H. Rajput et al.   NEUROLOGY

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY

Globus pallidus dopamine and Parkinson motor subtypes: Clinical and brain biochemical correlation

(2008) A. H. Rajput et al.   NEUROLOGY